Evidence map›Paper›PMID 42506478›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Transmitter-Free Interfacial Sensitization in ZnSe/ZnS Quantum Dots Enables Efficient Upconversion.

Yan Wang, Weizhe Hu, Haicheng Liu, Linhai Fu, Ting Yang, Xian Lin, Ye Dai, Guohong Ma, Quan Zhang, Jie Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yan WangDepartment of Physics, Shanghai University, Shanghai 200444, China.
Weizhe HuInstitute for Chemical Research, Kyoto University, Kyoto 611-0011, Japan.
Haicheng LiuDepartment of Physics, Shanghai University, Shanghai 200444, China.
Linhai FuDepartment of Physics, Shanghai University, Shanghai 200444, China.
Ting YangDepartment of Physics, Shanghai University, Shanghai 200444, China.
Xian LinDepartment of Physics, Shanghai University, Shanghai 200444, China.
Ye DaiDepartment of Physics, Shanghai University, Shanghai 200444, China.ORCID 0000-0002-9661-4626
Guohong MaDepartment of Physics, Shanghai University, Shanghai 200444, China.ORCID 0000-0002-3972-5012
Quan ZhangState Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China.ORCID 0000-0001-6265-9108
Jie ZhangDepartment of Physics, Shanghai University, Shanghai 200444, China.ORCID 0000-0002-3079-0977

Funding

China National Center for Biotechnology Development 2024YFA1209500Chunhui Plan Project of Ministry of Education of the People's Republic of China HZKY20220530National Natural Science Foundation of China 12274280National Natural Science Foundation of China 12574464
6 · The paper itself

Abstract

Triplet-triplet annihilation upconversion (TTA-UC) from the visible to ultraviolet (UV) holds promise for UV-driven photochemistry, yet the design principles governing interfacial triplet energy transfer (TET) and overall efficiency remain debated. Here, we compare two sensitization strategies for TTA-UC using ZnSe/ZnS core/shell quantum dots, including transmitter-mediated (with 4-biphenylcarboxylic acid, BCA) and transmitter-free direct assembly. Two high-triplet-energy annihilators, 2,6-di-tert-butylnaphthalene (DTBN) and p-terphenyl (TP), are investigated. Time-resolved photoluminescence reveals that while DTBN exhibits faster interfacial TET (

Indexed as

photon upconversionquantum dotstransmitter ligandstriplet energy transfertriplet–triplet annihilation

Identifiers

PMID42506478
PMCPMC13416163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.